Merck
  • Home
  • Search Results
  • Chemical inhibitors of CYP450 enzymes in liver microsomes: combining selectivity and unbound fractions to guide selection of appropriate concentration in phenotyping assays.

Chemical inhibitors of CYP450 enzymes in liver microsomes: combining selectivity and unbound fractions to guide selection of appropriate concentration in phenotyping assays.

Xenobiotica; the fate of foreign compounds in biological systems (2014-07-30)
Ramakrishna Nirogi, Raghava Choudary Palacharla, Venkatesham Uthukam, Arunkumar Manoharan, Surya Rao Srikakolapu, Ilayaraja Kalaikadhiban, Rajesh Kumar Boggavarapu, Ranjith Kumar Ponnamaneni, Devender Reddy Ajjala, Gopinadh Bhyrapuneni
ABSTRACT

1. Chemical inhibition is the widely used method in reaction phenotyping assays for estimation of specific enzyme contribution to a given metabolic pathway. The results from phenotyping assays depend on the selectivity of chemical inhibitor and the concentration of inhibitor used in the incubation. 2. The higher protein concentrations used in the in vitro phenotyping assays will impact the inhibitory potency of chemical inhibitors. The objective of the study is to evaluate comprehensively the selectivity of chemical inhibitors and to guide in selecting appropriate concentration of the chemical inhibitors to be used in the phenotyping assays based on unbound fractions. 3. Selectivity of chemical inhibitors against nine major CYP450 isoforms was determined in liver microsomes using standard probe substrates. The unbound fractions of the selective inhibitors were determined in human liver microsomes using high-throughput equilibrium dialysis. Combining unbound inhibitor concentrations that are required to inhibit the CYP450 activities by 90% and unbound fractions of the chemical inhibitors in liver microsomes appropriate total concentrations of the inhibitors to be used in the phenotyping assays were reported. 4. The findings suggest that non-specific binding of the chemical inhibitors need to be taken into account while selecting concentrations for phenotyping assays.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Furafylline, ≥98% (HPLC)
Supelco
8-Methoxypsoralen, analytical standard
Sigma-Aldrich
Sulfaphenazole, ≥98%
Sigma-Aldrich
Quinidine, anhydrous
Sigma-Aldrich
Umbelliferone, 99%
Sigma-Aldrich
4-Hydroxymephenytoin, ≥98% (HPLC)
Sigma-Aldrich
Fomepizole, 99%
Sigma-Aldrich
Acetaminophen, analytical standard
Sigma-Aldrich
Acetaminophen, BioXtra, ≥99.0%
Sigma-Aldrich
Acetaminophen, meets USP testing specifications, 98.0-102.0%, powder
Sigma-Aldrich
Umbelliferone, suitable for fluorescence indicator, ≥98.0% (HPLC)
Sigma-Aldrich
Quinidine, crystallized, ≥98.0% (dried material, NT)
Supelco
Ketoconazole, Pharmaceutical Secondary Standard; Certified Reference Material
Ketoconazole, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Sulfaphenazole, ≥98% (HPLC)
Sigma-Aldrich
4-Hydroxymephenytoin
Sigma-Aldrich
Ketoconazole
Supelco
Acetaminophen solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
USP
Ketoconazole, United States Pharmacopeia (USP) Reference Standard
USP
Acetaminophen, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Ketoconazole, 99.0-101.0% (EP, titration)
Sigma-Aldrich
Chlorzoxazone
Supelco
Xanthotoxin, analytical standard
Supelco
Umbelliferone, analytical standard
Supelco
Acetaminophen, Pharmaceutical Secondary Standard; Certified Reference Material
Paracetamol, European Pharmacopoeia (EP) Reference Standard
Supelco
Phenacetin, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Phenacetin melting point standard, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Coumarin, certified reference material, TraceCERT®
Coumarin, European Pharmacopoeia (EP) Reference Standard